Image pharmaphorum Editor White Papers Sponsored Ensuring successful digital outreach and retention in atopic... Trial organisers face intense competition to find and recruit eligible patients for atopic dermatitis studies. Views & Analysis Medical Informatics and Rare Disease: a bridge between two w... Today’s rare disease landscape comprises of around 7,000 different diseases. Patients From trial design for patients to trial design with patients... At the 2022 Drug Information Association (DIA) annual meeting last week, it was Market Access Pharma’s post-pandemic launch performance problem: what’s th... The prescription medicine market has recovered from the wild swings of the early pandemic with renewed growth. Load more results
White Papers Sponsored Ensuring successful digital outreach and retention in atopic... Trial organisers face intense competition to find and recruit eligible patients for atopic dermatitis studies.
Views & Analysis Medical Informatics and Rare Disease: a bridge between two w... Today’s rare disease landscape comprises of around 7,000 different diseases.
Patients From trial design for patients to trial design with patients... At the 2022 Drug Information Association (DIA) annual meeting last week, it was
Market Access Pharma’s post-pandemic launch performance problem: what’s th... The prescription medicine market has recovered from the wild swings of the early pandemic with renewed growth.
Patients Precision medicine in action, with Cary Claiborne Cary Claiborne, CEO of Adial Pharmaceuticals, discusses his company’s bet on a precision treatment for AUD.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
